Skip to main content

Better Plant Sciences Inc. (VEGGD)

New York Stock Exchange Healthcare Drug Manufacturers - Specialty & GenericView data quality →
34.0Poor

ValueMarkers Composite Index

Top 1%#44,288 of 44,714

DCF data not available

Piotroski
2/9
Weak
Beneish
-6.80
Low Risk
Altman
-41.39
Distress
DCF Value
-
N/A
ROIC
-4.0%
Low
P/E
-
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Better Plant Sciences Inc. (VEGGD) — VMCI valuation read

The headline on Better Plant Sciences Inc. (VEGGD) is a 34/100 VMCI score, set against a Healthcare sector median of 50. That 16-point below-median read reflects the five-pillar weighting and, for a mid-cap name, suggests a relative-value drag is in the data.

VEGGD insider activity report: 0 buys, 0 sells filed via Form 4 over the past 30 days. The next datable items are the 10-Q schedule and any 8-K-triggering events; both feed the VMCI Integrity pillar more than the price tape.

**Investor frame.** VEGGD trades at 19.0x earnings, 6% above the Healthcare median of 18.0x sets the value side. ROIC of 19.0% sits 9.0pp above the Healthcare median (10.0%) sets the quality side. Net debt to EBITDA of 2.0x is the rate-sensitivity line to watch sets the risk side, the three lines a value buyer reads first on VEGGD.

VEGGD fell 1.0% over the trailing 7 days, with a +6.4% read on a 30-day basis.

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in VEGGD’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.